Provided by Tiger Trade Technology Pte. Ltd.

Kymera Therapeutics, Inc.

109.33
-0.7900-0.72%
Volume:181.52K
Turnover:19.96M
Market Cap:9.09B
PE:-34.04
High:111.23
Open:111.23
Low:108.95
Close:110.12
52wk High:130.05
52wk Low:54.35
Shares:83.15M
Float Shares:66.33M
Volume Ratio:0.71
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2122
EPS(LYR):-3.6900
ROE:-24.15%
ROA:-15.59%
PB:6.02
PE(LYR):-29.63

Loading ...

Kymera Therapeutics to join Bank of America Healthcare Conference fireside chat

Reuters
·
May 06

Kymera says KT-579 Phase 1 healthy-volunteer trial data due in 2H 2026

Reuters
·
May 05

Jeito Capital appoints Elaine Caughey partner for business development, investor relations

Reuters
·
May 05

Barclays Sticks to Its Buy Rating for Kymera Therapeutics (KYMR)

TIPRANKS
·
May 01

Kymera Therapeutics price target lowered to $119 from $123 at Morgan Stanley

TIPRANKS
·
May 01

Earnings Flash (KYMR) Kymera Therapeutics Posts Q1 Net Loss $0.71 a Share, vs. FactSet Est of $0.88 Loss

MT Newswires Live
·
Apr 30

Kymera publishes corporate presentation on oral protein degraders for immunology medicines

Reuters
·
Apr 30

Kymera Therapeutics Q1 EPS $(0.71) Beats $(0.88) Estimate, Sales $34.365M Beat $8.614M Estimate

Benzinga Earnings
·
Apr 30

Kymera Q1 revenue jumps on Gilead milestone

Reuters
·
Apr 30

Kymera Q1 net loss widens to $69.2 million; collaboration revenues climb to $34.4 million

Reuters
·
Apr 30

BRIEF-Kymera Therapeutics Q1 EPS USD -0.71

Reuters
·
Apr 30

Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update

GlobeNewswire
·
Apr 30

Kymera CEO Nello Mainolfi disposes of common shares worth $2,430,898.39

Reuters
·
Apr 30

Kymera director Bruce Booth disposes of common shares worth $538,687

Reuters
·
Apr 25

Kymera COO Jeremy Chadwick disposes 300 shares for $27,000

Reuters
·
Apr 25

Kymera Therapeutics to report first-quarter financial results, host webcast call

Reuters
·
Apr 23

Kymera COO Jeremy Chadwick disposes of USD 589,510 Kymera Therapeutics shares

Reuters
·
Apr 17

Kymera Therapeutics Chief Business Officer Noah Goodman sells 1,347 shares for $121,230

Reuters
·
Apr 17

Kymera director Bruce Booth disposes of common shares worth $836,290.08

Reuters
·
Apr 17

BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune

Reuters
·
Apr 14